The DOI matches its Crossref record; 266 of the 266 references it cites were found in a registry or an index.
Molecular Properties of Bacterial Multidrug Transporters
Open accessAbstract
SUMMARY: One of the mechanisms that bacteria utilize to evade the toxic effects of antibiotics is the active extrusion of structurally unrelated drugs from the cell. Both intrinsic and acquired multidrug transporters play an important role in antibiotic resistance of several pathogens, including Neisseria gonorrhoeae, Mycobacterium tuberculosis, Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Vibrio cholerae. Detailed knowledge of the molecular basis of drug recognition and transport by multidrug transport systems is required for the development of new antibiotics that are not extruded or of inhibitors which block the multidrug transporter and allow traditional antibiotics to be effective. This review gives an extensive overview of the currently known multidrug transporters in bacteria. Based on energetics and structural characteristics, the bacterial multidrug transporters can be classified into five distinct families. Functional reconstitution in liposomes of purified multidrug transport proteins from four families revealed that these proteins are capable of mediating the export of structurally unrelated drugs independent of accessory proteins or cytoplasmic components. On the basis of (i) mutations that affect the activity or the substrate specificity of multidrug transporters and (ii) the three-dimensional structure of the drug-binding domain of the regulatory protein BmrR, the substrate-binding site for cationic drugs is predicted to consist of a hydrophobic pocket with a buried negatively charged residue that interacts electrostatically with the positively charged substrate. The aromatic and hydrophobic amino acid residues which form the drug-binding pocket impose restrictions on the shape and size of the substrates. Kinetic analysis of drug transport by multidrug transporters provided evidence that these proteins may contain multiple substrate-binding sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whole-Genome Random Sequencing and Assembly of Haemophilus influenzae Rd
Fleischmann, R. D., Adams, M. D., White, O., Clayton, R. A., Kirkness, E. F., Kerlavage, A. R., Bult, C. J., Tomb, J.-F., Dougherty, B. A., Merrick, J. M., et al. (1995) · Science · doi:10.1126/science.7542800 · Cited by 5,654
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312 · cited 1×
“In general, ABC transporters require four distinct domains: two highly hydrophobic membrane domains, which usually consist of six putative transmembrane a-helices each, and two hydrophilic nucleotide-binding domains (NBDs), containing the Walker A and B motifs (263) and the ABC signature (96).”
BackgroundABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985 · cited 2×
“The individual domains can be expressed as separate proteins or may be fused into multidomain polypeptides in a variety of ways (55, 87, 96).”
BackgroundBIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834 · cited 1×
“However, the subsequent appearance and spread of antibiotic resistance in pathogenic organisms have made many currently available antibiotics ineffective (160, 169).”
BackgroundCation-π Interactions in Chemistry and Biology: A New View of Benzene, Phe, Tyr, and Trp
Dougherty, D. A. (1996) · Science · doi:10.1126/science.271.5246.163 · Cited by 2,656
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Molecular basis of bacterial outer membrane permeability
Nikaido, H., & Vaara, M. (1985) · Microbiological Reviews · doi:10.1128/mmbr.49.1.1-32.1985 · Cited by 2,447
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
Inactivation of Antibiotics and the Dissemination of Resistance Genes
Davies, J. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,730
Cited by
An overview of the antimicrobial resistance mechanisms of bacteria
C Reygaert, W., & Department of Biomedical Sciences, O. U. W. B. S. O. M. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.3.482 · Cited by 1,893
Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems
Davidson, A. L., Dassa, E., Orelle, C., & Chen, J. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-07 · Cited by 1,420
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
The Transporter Classification Database (TCDB): recent advances
Saier, M. H., Reddy, V. S., Tsu, B. V., Ahmed, M. S., Li, C., & Moreno-Hagelsieb, G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1103 · Cited by 999
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 928
Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations
Sun, J., Deng, Z., & Yan, A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.090 · Cited by 746
Ruiz, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg222 · Cited by 711
Molecular Insights into Aminoglycoside Action and Resistance
Magnet, S., & Blanchard, J. S. (2005) · Chemical Reviews · doi:10.1021/cr0301088 · Cited by 669
Analysis of a Complete Library of Putative Drug Transporter Genes in Escherichia coli
Nishino, K., & Yamaguchi, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.20.5803-5812.2001 · Cited by 666
Stress responses in lactic acid bacteria
van de Guchte, M., Serror, P., Chervaux, C., Smokvina, T., Ehrlich, S. D., & Maguin, E. (2002) · Antonie van Leeuwenhoek · doi:10.1023/a:1020631532202 · Cited by 648
“MDR efflux systems have been well studied in several Gram-positive bacteria including B. subtilis, S. pneumoniae and L. lactis (Putman et al. 2000) but the role of efflux in bile resistance has not yet been established.”
BackgroundEfflux-mediated multiresistance in Gram-negative bacteria
Poole, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00763.x · Cited by 613
Buffet-Bataillon, S., Tattevin, P., Bonnaure-Mallet, M., & Jolivet-Gougeon, A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.01.011 · Cited by 601
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
A human transporter protein that mediates the final excretion step for toxic organic cations
Otsuka, M., Matsumoto, T., Morimoto, R., Arioka, S., Omote, H., & Moriyama, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506483102 · Cited by 571
Efflux pumps as antimicrobial resistance mechanisms
Poole, K. (2007) · Annals of Medicine · doi:10.1080/07853890701195262 · Cited by 562
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance
Hooper, D. C., & Jacoby, G. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025320 · Cited by 553
CmeABC Functions as a Multidrug Efflux System in Campylobacter jejuni
Lin, J., Michel, L. O., & Zhang, Q. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2124-2131.2002 · Cited by 528
Mechanisms of bacterial biocide and antibiotic resistance: ANTIBIOTIC AND BIOCIDE RESISTANCE
Poole, K. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.8.x · Cited by 513
Engineering microbial biofuel tolerance and export using efflux pumps
Dunlop, M. J., Dossani, Z. Y., Szmidt, H. L., Chu, H. C., Lee, T. S., Keasling, J. D., Hadi, M. Z., & Mukhopadhyay, A. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.21 · Cited by 512
Antimicrobial resistance, mechanisms and its clinical significance
Abushaheen, M. A., Muzaheed, Fatani, A. J., Alosaimi, M., Mansy, W., George, M., Acharya, S., Rathod, S., Divakar, D. D., Jhugroo, C., et al. (2020) · Disease-a-Month · doi:10.1016/j.disamonth.2020.100971 · Cited by 511
Structures and General Transport Mechanisms by the Major Facilitator Superfamily (MFS)
Drew, D., North, R. A., Nagarathinam, K., & Tanabe, M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00983 · Cited by 465
The Transporter Classification Database (TCDB): 2021 update
Saier, M. H., Reddy, V. S., Moreno-Hagelsieb, G., Hendargo, K. J., Zhang, Y., Iddamsetty, V., Lam, K. J. K., Tian, N., Russum, S., Wang, J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1004 · Cited by 467
Triclosan: a widely used biocide and its link to antibiotics
Schweizer, H. (2001) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00273-7 · Cited by 447
Beer spoilage bacteria and hop resistance
Sakamoto, K., & Konings, W. N. (2003) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(03)00153-3 · Cited by 444
Self-citationWales, A., & Davies, R. (2015) · Antibiotics · doi:10.3390/antibiotics4040567 · Cited by 443
The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations
Omote, H., Hiasa, M., Matsumoto, T., Otsuka, M., & Moriyama, Y. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.001 · Cited by 432
Cation–π interactions in ligand recognition and catalysis
Zacharias, N. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02027-8 · Cited by 430
Modes and Modulations of Antibiotic Resistance Gene Expression
Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., & Courvalin, P. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00015-06 · Cited by 427
Regulation of bacterial drug export systems
Grkovic, S., Brown, M. H., & Skurray, R. A. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.4.671-701.2002 · Cited by 423
Environmental stress responses in Lactobacillus: A review
De Angelis, M., & Gobbetti, M. (2004) · PROTEOMICS · doi:10.1002/pmic.200300497 · Cited by 422
Chang, Y.-T., Lin, C.-Y., Chen, Y.-H., & Hsueh, P.-R. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00893 · Cited by 419
Structure of the Multidrug Transporter EmrD from Escherichia coli
Yin, Y., He, X., Szewczyk, P., Nguyen, T., & Chang, G. (2006) · Science · doi:10.1126/science.1125629 · Cited by 387
Intelligent, self-powered, drug delivery systems
Patra, D., Sengupta, S., Duan, W., Zhang, H., Pavlick, R., & Sen, A. (2013) · Nanoscale · doi:10.1039/c2nr32600k · Cited by 375
Use of antimicrobials in veterinary medicine and mechanisms of resistance
Schwarz, S., & Chaslus-Dancla, E. (2001) · Veterinary Research · doi:10.1051/vetres:2001120 · Cited by 370
Structural Mechanisms of QacR Induction and Multidrug Recognition
Schumacher, M. A., Miller, M. C., Grkovic, S., Brown, M. H., Skurray, R. A., & Brennan, R. G. (2001) · Science · doi:10.1126/science.1066020 · Cited by 368
Contribution of the Mycobacterium tuberculosis MmpL Protein Family to Virulence and Drug Resistance
Domenech, P., Reed, M. B., & Barry, C. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3492-3501.2005 · Cited by 361
Structure and Function of TolC: The Bacterial Exit Duct for Proteins and Drugs
Koronakis, V., Eswaran, J., & Hughes, C. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074104 · Cited by 357
Vancomycin Assembly: Nature's Way
Hubbard, B. K., & Walsh, C. T. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390202 · Cited by 356
Lubelski, J., Konings, W. N., & Driessen, A. J. M. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00001-07 · Cited by 339
Self-citationLi, L., He, Z., Pandey, G. K., Tsuchiya, T., & Luan, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108777200 · Cited by 335
Fluoroquinolone resistance among Gram-positive cocci
Hooper, D. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00369-9 · Cited by 320
Small multidrug resistance proteins: A multidrug transporter family that continues to grow
Bay, D. C., Rommens, K. L., & Turner, R. J. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.015 · Cited by 299
ABC-transporters: implications on drug resistance from microorganisms to human cancers
Lage, H. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00203-6 · Cited by 298
MgrA Is a Multiple Regulator of Two New Efflux Pumps in Staphylococcus aureus
Truong-Bolduc, Q. C., Dunman, P. M., Strahilevitz, J., Projan, S. J., & Hooper, D. C. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2395-2405.2005 · Cited by 296
Engineering microbes for tolerance to next-generation biofuels
Dunlop, M. J. (2011) · Biotechnology for Biofuels · doi:10.1186/1754-6834-4-32 · Cited by 293
Li, D., Yu, T., Zhang, Y., Yang, M., Li, Z., Liu, M., & Qi, R. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.02964-09 · Cited by 292
Conformational Flexibility in the Multidrug Efflux System Protein AcrA
Mikolosko, J., Bobyk, K., Zgurskaya, H. I., & Ghosh, P. (2006) · Structure · doi:10.1016/j.str.2005.11.015 · Cited by 279
Kaatz, G. W., McAleese, F., & Seo, S. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1857-1864.2005 · Cited by 279
Exploring phytochemicals for combating antibiotic resistance in microbial pathogens
Khare, T., Anand, U., Dey, A., Assaraf, Y. G., Chen, Z.-S., Liu, Z., & Kumar, V. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.720726 · Cited by 281
Structure and function of efflux pumps that confer resistance to drugs
BORGES-WALMSLEY, M. I., McKEEGAN, K. S., & WALMSLEY, A. R. (2003) · Biochemical Journal · doi:10.1042/bj20020957 · Cited by 278
Multidrug resistance in Gram-negative bacteria
Poole, K. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00242-3 · Cited by 275
Bacterial efflux systems and efflux pumps inhibitors
Marquez, B. (2005) · Biochimie · doi:10.1016/j.biochi.2005.04.012 · Cited by 270
Périchon, B., Courvalin, P., & Galimand, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00143-07 · Cited by 266
A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
Louw, G. E., Warren, R. M., Gey van Pittius, N. C., McEvoy, C. R. E., Van Helden, P. D., & Victor, T. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01577-08 · Cited by 263
The Role of Secretion Systems and Small Molecules in Soft-Rot Enterobacteriaceae Pathogenicity
Charkowski, A., Blanco, C., Condemine, G., Expert, D., Franza, T., Hayes, C., Hugouvieux-Cotte-Pattat, N., Solanilla, E. L., Low, D., Moleleki, L., et al. (2012) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-081211-173013 · Cited by 260
Ortega Morente, E., Fernández-Fuentes, M. A., Grande Burgos, M. J., Abriouel, H., Pérez Pulido, R., & Gálvez, A. (2013) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2012.12.028 · Cited by 254
High level cell‐free expression and specific labeling of integral membrane proteins
Klammt, C., Löhr, F., Schäfer, B., Haase, W., Dötsch, V., Rüterjans, H., Glaubitz, C., & Bernhard, F. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2003.03959.x · Cited by 253
Isoprenoid drugs, biofuels, and Chemicals–Artemisinin, farnesene, and beyond
George, K. W., Alonso-Gutierrez, J., Keasling, J. D., & Lee, T. S. (2015) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2014_288 · Cited by 185
“The best-studied solvent tolerance pumps are those from the resistance–nodulation–division (RND) family in gram-negative bacteria, but many other organisms also harbor efflux pumps [108].”
BackgroundRole of Quaternary Ammonium Compounds on Antimicrobial Resistance in the Environment
Tezel, U., & Pavlostathis, S. G. (2011) · Antimicrobial Resistance in the Environment · doi:10.1002/9781118156247.ch20 · Cited by 90
“There are five classes ofmultidrug efflux systems: small multidrug resistance (SMR) family, drug/metabolite transporter (DMT) superfamily, major facilitator superfamily (MFS), ATP-binding cassette (ABC) family, resistance–nodulation–division (RND) family, and the multidrug and toxic compound extrusion (MATE) family (P…”
BackgroundStructure and mechanism of a tripartite ATP-independent periplasmic TRAP transporter
Davies, J. S., Currie, M. J., North, R. A., Scalise, M., Wright, J. D., Copping, J. M., Remus, D. M., Gulati, A., Morado, D. R., Jamieson, S. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36590-1 · Cited by 34
(2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11
Sharma, S., Banerjee, A., Moreno, A., Redhu, A. K., Falson, P., & Prasad, R. (2022) · Journal of Fungi · doi:10.3390/jof8050538 · Cited by 1
Metadata
- Authors
- Putman, M., van Veen, H. W., & Konings, W. N.
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2000-12
- Volume
- 64
- Issue
- 4
- Pages
- 672-693
- ISSN
- 1092-2172 (ISSN-L)
- 1098-5557
- OpenAlex
- W2106192857
- Cited by
- 795
- References
- 266
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.